- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 6, 2026 | 2.87M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 2.41M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 1.84M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$4.65M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $2.31M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $4.01M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.8M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.74M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $6.11M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $7.44M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.06M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.59M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.06M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.59M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.86M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $4.32M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.86M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.33M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.04 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$2.09 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.04 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$2.09 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.74M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $2.25M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $771.51K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.67M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.5M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$3.85M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2.51M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$3.93M |
| Capex | Q1 2026 · Mar 31, 2025 | $3.25K |